Patients News | pharmaphorum

News

Remote Parkinson’s monitoring tech backed by NICE

In its second guidance on digital health technologies within a week, NICE has endorsed five remote monitoring devices for patients with Parkinson’s disease that can be use

News

Lilly trumpets early success with deafness gene therapy

Eli Lilly’s acquisition of gene therapy specialist Akouos seems to have paid off, after the lead candidate in the deal restored hearing in a child with congenital deafness

News

Trial raises hopes for simple Alzheimer’s blood test

Testing a person’s blood for a protein called phosphorylated tau could provide a means of large-scale screening for Alzheimer’s disease (AD), according to a new study.

News

Next stage in GSK’s Zantac defense gets underway today

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients.

News

NICE backs Pfizer’s Talzenna for advanced breast cancer

Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recomm

News

Professor Bola Owolabi, director of the National Healthcare Inequalities Improvement Programme at NHS England

Winners named in NHS healthcare inequality contest

A competition aimed at tackling unequal access to healthcare in the NHS has been won by C2-Ai, a company that has developed an artificial intelligence-based risk assessmen

Remote Parkinson’s monitoring tech backed by NICE

Lilly trumpets early success with deafness gene therapy

Trial raises hopes for simple Alzheimer’s blood test

Next stage in GSK’s Zantac defense gets underway today

NICE backs Pfizer’s Talzenna for advanced breast cancer

Winners named in NHS healthcare inequality contest

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks